Latest Headlines

  1. Warehouse Monitoring: Medical/Surgical Supply Distributor Improves Efficiency And Compliance
    9/22/2014

    Owens & Minor, Mechanicsville, VA, is a leading U.S. supplier of medical and surgical products to hospitals, integrated healthcare systems, alternate care locations, and the federal government.

  2. EMA, EC, NICE Weekly News Roundup: Roche, GSK, Janssen, And More
    9/19/2014

    Roche’s and Chugai Pharma’s RoACTEMRA was approved in the EU for those with severe rheumatoid arthritis (RA) that were not previously treated with methotrexate (MTX).

  3. India Envisages Exports Expansion In Latin America And Places Renewed Focus And Investment On Safeguarding The Quality Of Drugs Produced
    9/18/2014

    IBEF (India Brand Equity Foundation) recently announced the sustained collective efforts being made by the pharmaceutical industry and Government for sustaining the export growth trajectory. 

  4. Strike Bio Purchases ISO-7 Cleanroom Pod For Personalized Drug Manufacturing
    9/18/2014

    G-CON Manufacturing, Inc., the manufacturer of autonomous cleanroom PODs™, is pleased to announce that Strike Bio, Inc. has selected G-CON to provide an ISO 7 cleanroom POD to further advance its specific protein knockdown bifunctional short hairpin RNA (shRNA) technology.

  5. CSafe Continues To Expand Service Network With IAD And SEA Locations
    9/18/2014

    CSafe announced recently that it has subcontracted maintenance and repair services for their CSafe RKN at both the Seattle and Dulles International Airports. This notice follows their June announcement of the opening of their CSafe managed service center in San Francisco.

  6. Weekly News Roundup For Pharma Manufacturers — September 17, 2014
    9/17/2014

    In the news this week, generics are saving the U.S. health system trillion; “shadow” pharma contract manufacturing is on the rise; and a market survey shows that conventional tablet formulations could be losing patients’ favor. Several countries are also experiencing drug shortages, leaving many desperate for viable treatment.

  7. Micromeritics To Participate In University Of Maryland Tableting Course
    9/16/2014

    This October, the University of Maryland School of Pharmacy will hold its second annual Tablets & Capsules Hands-On Short Course.

  8. Weekly FDA Enforcement Report For Drugs 9/10/14
    9/15/2014

    The Food and Drug Administration (FDA) has released its Drug product Enforcement Report for September 10, 2014. The agency publicizes recalls in its weekly report as press releases are not issued for all recalls. Manufacturers issue recalls voluntarily or the FDA initiates the action. View the recalls by Classification.

  9. FDA News Roundup: Astellas, Sanofi Pasteur, Orexigen, and More
    9/15/2014

    Biopharmaceutical company Molecular Templates got a nod of approval from the FDA on its Investigational New Drug (IND) application for MT-3724 last week. MT-3724 is a next-generation immunotoxin compound that induces direct cell death by inactivating ribosomes in CD20-expressing cells. Now that approval has been granted, the company plans to launch a phase 1 clinical trial program for the drug candidate, investigating its potential as a monotherapy in refractory non-Hodgkin’s lymphoma. The study will be held at Memorial Sloan-Kettering Cancer Center and New York University’s Langone Medical Center, joined eventually by a site in an oncology center in Texas.

  10. FDA News Roundup: Actavis, Debiopharm, Merck, Astellas, And More
    9/11/2014

    The FDA has been busy the past week granting fast-track status to drugs from Acadia, Ipsen, VentiRx, Merck, and Aradigm. The agency has also approved, reviewed, and granted orphan drug/QIDP designations to Debiopharm, Prana, and more.

Newsletter Signup
Newsletter Signup
By clicking Sign Me Up, you agree to our Terms and that you have read our Privacy Policy.